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Peptides are important regulators of growth and cellular functions not only in normal tissue 
but also in tumors. Peptides are becoming of increasing interest in nuclear oncology for 
targeted tumor diagnosis and therapy. 111In-diethylenetriaminepentaacetic acid (111In-DTPA) 
labelled Octreotide (Octreoscan; Mallinckrodt / Inc.) was the first routinely used tracer in 
nuclear medicine for the localization and staging of somatostatin receptor positive tumors. 
Stable somatostatin derivatives such as Octreotide / Lantrotide are the most frequently used 
radiopharmaceuticals acting through specific binding to somatostatin receptors; however, 
they do not bind with high affinity to all five receptor subtypes. 111In-DTPA-Octreotide based 
imaging served as a sensitive and specific technique for somatostatin receptor scintigraphy 
that can detect in-vivo somatostatin receptors in various tumors mainly of endocrine origin. 
111In-DTPA-Octreotide is commercially available for imaging; however the use of 111In as a 
radioisotope entails high cost, limited availability, suboptimal image quality and a high 
radiation burden to the patient. These disadvantages were overcome by the use of 99mTc 
labelled somatostatin analogs. Thus newly developed somatostatin analogs labelled with 
99mTc were intensively studied in the proposed research work. 
New somatostatin analogs (octreotide derivatives) like HYNIC-Tyr3-Octreotide 
(TOC), HYNIC-His3-Octreotate and HYNIC-Met3-Octreotate (TATE) were synthesized by 
standard Fmoc Solid Phase Peptide Synthesis (SPPS) on O-t-butylthreoninol-2-chloro trityl 
resin for TOC derivatives and H-Thr(tBu)-2-Cl trityl resin for TATE derivatives on a semi 
automated peptide synthesizer according  to our laboratory protocol. Coupling of prochelator 
to peptide was performed in the presence of excess of HYNIC-BOC in solid phase. BOC 
protected HYNIC was also synthesized and characterized in our laboratory. Then the peptide 
chains were cyclized by formation of cys-cys disulfide bond through Iodine oxidation 
method. These peptides were deblocked and deprotected from resin and lateral protecting 
groups by using trifluoro acetic acid cocktail. Then purification was achieved by semi-
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preparative HPLC. The structures of the peptides were then elucidated by 1D NMR (1H 
NMR, 13C NMR, DEPT 90, 135), 2D NMR (HSQC, HMBC, COSY), MALDI mass and FT-
IR spectroscopy. The peptides were again quantitated by amino acid analysis of a 24 h acid 
hydrolysate using Waters Accu-Tag chemistry together with a Waters HPLC system. 
Conformational analysis of the peptides was performed by circular dichorism spectroscopy in 
pure water and trifluroethanol-water (1:1). 
Labelling of peptides was performed with 99mTc using Tricine and EDDA as 
coligands by SnCl2 method to get products with excellent radiochemical purity ˃98%. 
Complexation efficiency and radiochemical purity of radiolabelled peptides were validated 
by ITLC and RP-HPLC.  In-vitro stability study on rat serum and PBS buffer pH 7.4 was 
performed. The percentages of radiolabelled complex and free pertechnetate were assessed by 
ITLC method. The stability of radiolabelled peptides was validated by RP-HPLC. Metabolic 
stabilities in rat kidney and urine indicate that the radio peptides were stable to enzymatic 
changes. Metabolic stability analysis did not show any evidence of breaking of the labelled 
compounds and formation of free 99mTc.  
C6 glioma cell (NCCS, Pune, India) was grown confluent in DMEM high glucose 
nutrient mixture supplemented by 10-20% (v/v) fetal bovine serum, 1 mM glutamine, 100 
U/ml penicillin and 100 μg/ml streptomycin in humidified air containing 5% CO2 at 37 °C. 
Internalization studies were done and IC50 values were determined in somatostatin receptor-
expressing C6 glioma cell line and rat brain cortex membrane, and the results compared 
against HYNIC-TOC as standard. Radioligand internalization, in-vitro receptor binding 
assays, blood clearance, scintigraphy, and biodistribution studies were performed to evaluate 
their biological characteristics. The results of scintigraphy imaging studies and renogram 
study also showed the highest uptake in the kidney which gradually decreased as time passed. 
Blood clearance was faster with rapid excretion through kidneys. Biodistribution and image  
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